In chronic lymphocytic leukemia (CLL), the overexpression of IBTK has been correlated with disease progression and proved essential for B cell survival under stress induced by chemotherapeutic agents (3). This evidence concerns the gene IBTK and B-cell chronic lymphocytic leukemia.